1-3 of 3
Sari Hernesniemi
Close
Sort by
Journal Articles

Single-Cell Profiling of Aberrant Cytokine Signaling in Patients with Chronic Myeloid Leukemia (CML) at Diagnosis and during Dasatinib Therapy

Sari Hernesniemi, Jukka Vakkila, MD, PhD, Kimmo Porkka, MD, PhD, Satu Mustjoki, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 4214.
https://doi.org/10.1182/blood.V112.11.4214.4214
Published: 2008
Journal Articles

Low or Undetectable Numbers of Philadelphia Chromosome Positive (Ph+) Leukemia Cells in the Primitive ( CD34 pos CD38 neg ) Stem Cell Fraction in Chronic Myeloid Leukemia (CML) Patients during Tyrosine Kinase Inhibitor Therapy.

Satu Mustjoki, MD, PhD, Peter Rohon, MD, Katrin Rapakko, MSc, PhD, Sari Hernesniemi, MSc, Perttu Koskenvesa, MD, Tuija Lundán, MSc, PhD, Kimmo Porkka, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 1079.
https://doi.org/10.1182/blood.V112.11.1079.1079
Published: 2008
Journal Articles

Clonal Expansion of T/NK-Cells during Tyrosine Kinase Inhibitor Dasatinib Therapy

Satu Mustjoki, MD, PhD, Marja Ekblom, MD, PhD, T. Petteri Arstila, MD, PhD, Ingunn Dybedal, MD, PhD, PK Epling- Burnette, PhD, Felix Garzon, MD, PhD, Tobias Gedde-Dahl, MD, PhD, Sari Hernesniemi, MSc, Henrik Hjorth-Hansen, MD, PhD, Martin Hoglund, MD, PhD, Vesa Juvonen, PhD, Veli Kairisto, MD, PhD, Panu Kovanen, MD, PhD, Anna Kreutzman, MSc, Tuisku Laurinolli, Jane Liesveld, MD, Ronald Paquette, MD, Javier Pinilla, MD, PhD, Auvo Rauhala, MD, PhD, Neil Shah, MD, PhD, Bengt Simonsson, MD, PhD, Marjatta Sinisalo, MD, PhD, Juan Luis Steegmann, MD, PhD, Leif Stenke, MD, PhD, Jukka Vakkila, MD, PhD, Kimmo Porkka, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 573.
https://doi.org/10.1182/blood.V112.11.573.573
Published: 2008